BIOTECHNOLOGY VALUE FUND L P - 31 Mar 2025 SCHEDULE 13G/A Report for Elevation Oncology, Inc. Common Stock, par value $0.0001 per share (ELEV)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Elevation Oncology, Inc. Common Stock, par value $0.0001 per share
Symbol
ELEV
Shares outstanding
63,428,571 shares
Disclosed Ownership
4,440,000 shares
Ownership
7%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:27:14 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 3.9% 2,374,712 0 2,374,712 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 3.9% 2,374,712 0 2,374,712 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3% 1,826,364 0 1,826,364 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3% 1,826,364 0 1,826,364 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 210,388 0 210,388 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 210,388 0 210,388 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 6.6% 4,201,076 0 4,201,076 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 7% 4,440,000 0 4,440,000 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 7% 4,440,000 0 4,440,000 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 7% 4,440,000 0 4,440,000 /s/ Mark N. Lampert Mark N. Lampert